PH15937A - Thiazolidine derivatives and their pharmaceutical compositions - Google Patents

Thiazolidine derivatives and their pharmaceutical compositions

Info

Publication number
PH15937A
PH15937A PH25117A PH25117A PH15937A PH 15937 A PH15937 A PH 15937A PH 25117 A PH25117 A PH 25117A PH 25117 A PH25117 A PH 25117A PH 15937 A PH15937 A PH 15937A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
thiazolidine derivatives
thiazolidine
derivatives
pharmaceutical
Prior art date
Application number
PH25117A
Other languages
English (en)
Inventor
Kawamatsu Yutaka
Yamamoto Yujiro
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP755880A external-priority patent/JPS56104876A/ja
Priority claimed from JP10471880A external-priority patent/JPS5728075A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of PH15937A publication Critical patent/PH15937A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PH25117A 1980-01-24 1981-01-21 Thiazolidine derivatives and their pharmaceutical compositions PH15937A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP755880A JPS56104876A (en) 1980-01-24 1980-01-24 Thiazolidine derivative
JP10471880A JPS5728075A (en) 1980-07-29 1980-07-29 Thiazolidine derivative

Publications (1)

Publication Number Publication Date
PH15937A true PH15937A (en) 1983-04-29

Family

ID=26341877

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25117A PH15937A (en) 1980-01-24 1981-01-21 Thiazolidine derivatives and their pharmaceutical compositions

Country Status (9)

Country Link
US (1) US4387101A (el)
EP (1) EP0033617A3 (el)
AR (1) AR228144A1 (el)
AU (1) AU6610081A (el)
DK (1) DK30781A (el)
ES (1) ES8301951A1 (el)
GR (1) GR72992B (el)
PH (1) PH15937A (el)
PT (1) PT72390B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58177983A (ja) * 1982-04-13 1983-10-18 Takeda Chem Ind Ltd チアゾリジン誘導体
EP0117035B1 (en) * 1983-01-17 1989-08-16 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
JPS6143114A (ja) * 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
US5366985A (en) * 1991-03-27 1994-11-22 Senju Pharmaceutical Co., Ltd. Method for preparation of an aqueous suspension
EP0915090A1 (en) * 1992-09-10 1999-05-12 Eli Lilly And Company Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
JP3906935B2 (ja) * 1995-12-18 2007-04-18 杏林製薬株式会社 N−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
EP1128832A4 (en) * 1998-08-21 2003-03-05 Viropharma Inc COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
AU773505B2 (en) * 1999-06-18 2004-05-27 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2255903A (en) * 1938-07-25 1941-09-16 Lilly Co Eli 5,5-disubstituted-2,4-thiazolidiones, and process of making them
FR909629A (fr) * 1944-05-25 1946-05-14 Ste Ind Chim Bale Procédé pour lutter contre les organismes nuisibles
US2678318A (en) * 1949-08-19 1954-05-11 Beecham Res Lab Preparation of alpha-amino acids
FR1222411A (fr) * 1955-05-19 1960-06-09 Searle & Co Procédé de préparation de 2,4-diaminothiazols contenant un radical aryle halogéné
NL265085A (el) * 1960-05-24
US3825553A (en) * 1970-05-05 1974-07-23 Rorer Inc William H Certain 5-arylthiazolidines
US3864384A (en) * 1970-05-05 1975-02-04 Rorer Inc William H Substituted phenylacetic acid compounds
YU37171B (en) * 1975-12-05 1984-08-31 Krka Novo Mesto Process for preparing 7-(d-2-amino-2-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid
DE2655369A1 (de) * 1976-12-03 1978-06-08 Schering Ag 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
DE2862059D1 (en) * 1977-12-29 1982-11-11 Synthelabo Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Also Published As

Publication number Publication date
GR72992B (el) 1984-01-23
PT72390B (en) 1981-12-21
EP0033617A3 (en) 1981-08-26
DK30781A (da) 1981-07-25
PT72390A (en) 1981-02-01
ES508490A0 (es) 1982-12-16
ES8301951A1 (es) 1982-12-16
US4387101A (en) 1983-06-07
AR228144A1 (es) 1983-01-31
AU6610081A (en) 1981-07-30
EP0033617A2 (en) 1981-08-12

Similar Documents

Publication Publication Date Title
IL57450A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing them
IL63428A0 (en) Thiazoline derivatives,their preparation and pharmaceutical compositions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
PH15937A (en) Thiazolidine derivatives and their pharmaceutical compositions
NZ201833A (en) Thieno-and furopyridinium-substituted cephalosporin derivatives and pharmaceutical compositions
PH17562A (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
NZ210105A (en) Oxazolidine derivatives and pharmaceutical compositions
PH20168A (en) 7-carboxymethoxyphenylacetamino-3-cephem derivatives and their pharmaceutical compositions
IL65285A0 (en) Thiazole derivatives,their manufacture and pharmaceutical compositions containing them
NZ198862A (en) Enkephalin derivatives and pharmaceutical compositions
IL72139A0 (en) Thiazolidine derivatives,their manufacture and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
NZ198414A (en) Quinolone derivatives and pharmaceutical compositions
NZ192142A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ197564A (en) Cephalosporin sulphoxide derivatives and pharmaceutical compositions
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
NZ205732A (en) Thiatriazine derivatives and pharmaceutical compositions
IL66954A0 (en) Oxazolidinedione derivatives and pharmaceutical compositions containing them
NZ203649A (en) 2-beta-d-ribofuranosylselenazole-4-carboxamide derivatives and pharmaceutical compositions
GB2079285B (en) Dipthosphonate derivatives and pahrmaceutical compositions containing them
NZ205716A (en) Piperidine derivatives and pharmaceutical compositions
IL62400A0 (en) Thiazole derivatives,their preparation and pharmaceutical compositions containing them